If you made any changes in Pure these will be visible here soon.

Personal profile

Diplomas

Areas of expertise

Awards

External responsibilities

CEO of QUALIblood sa

Co-Chairman of the SSC Control of Anticoagulation of the Interntional Society on Thrombosis and Hemostasis

Pharmacovigilance Expert at the Federal Agency of Medicines and Health Products

Education/Academic qualification

Doctor of Pharmacy, University of Namur

Master of Pharmacy, Université Catholique de Louvain (UCL)

Bachelor of Pharmacy, University of Namur

External positions

Chief Executive Officer, Qualiblood

Nov 2017 → …

Co-Chairman, International Society on Thrombosis and Haemostasis

Nov 2016 → …

Fingerprint Dive into the research topics where Jonathan Douxfils is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles
Anticoagulants Medicine & Life Sciences
Thrombin Medicine & Life Sciences
Hemorrhage Medicine & Life Sciences
Prothrombin Time Medicine & Life Sciences
Heparin Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Partial Thromboplastin Time Medicine & Life Sciences
Atrial Fibrillation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2011 2019

Research Output 2010 2019

Andexanet alfa for the reversal of factor Xa inhibitors

Favresse, J., Hardy, M., van Dievoet, M. A., Sennesael, A. L., Douxfils, J., Samama, C. M., Vornicu, O., Dincq, A. S., Lessire, S. & Mullier, F., 2019, In : Expert Opinion on Biological Therapy. 19, 5, p. 387-397 11 p.

Research output: Contribution to journalReview article

Pharmacodynamics
Hemorrhage
Phase III Clinical Trials
Factor Xa
Pharmacokinetics

An update on laboratory assessment for direct oral anticoagulants (DOACs)

Gosselin, R. C., Adcock, D. M. & Douxfils, J., 2019, In : International Journal of Laboratory Hematology. 41 Suppl 1, p. 33-39 7 p.

Research output: Contribution to journalReview article

Anticoagulants
Pharmacodynamics
Pharmacokinetics
Antithrombins
Warfarin

Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application

Douxfils, J., Morimont, L., Bouvy, C., de Saint-Hubert, M., Devalet, B., Devroye, C., Dincq, A-S., Dogné, J-M., Guldenpfennig, M., Baudar, J., Larock, A-S., Lessire, S. & Mullier, F., 2019, In : Journal of thrombosis and haemostasis : JTH.

Research output: Contribution to journalArticle

Thrombin
Freezing
Reference Values
Low Molecular Weight Heparin
Anticoagulants

Prizes

55th ASH Annual Meeting and Exposition - Abstract Achievement Award

Jonathan Douxfils (Recipient), 7 Dec 2013

Prize: Prize (including medals and awards)

56th ASH Annual Meeting and Exposition - Abstract Achievement Award

Jonathan Douxfils (Recipient), 6 Dec 2014

Prize: Prize (including medals and awards)

58th Annual SSC Meeting of the ISTH - Young Investigators Awards

Jonathan Douxfils (Recipient), 26 Jun 2012

Prize: Prize (including medals and awards)

Eberhard F. Mammen Young Investigator Award 2019

Jonathan Douxfils (Recipient), 2019

Prize: National/international honour

Prix Léo Pharma Cancer & Thrombosis

Hélène Haguet (Recipient), Jonathan Douxfils (Recipient), François Mullier (Recipient) & Jean-Michel Dogne (Recipient), 25 Feb 2017

Prize: Prize (including medals and awards)

Activities 2010 2019

A new algorithm based on thrombin generation to assess hormone-relatedprothrombotic changes

Jonathan Douxfils (Invited speaker)
9 Jul 2019

Activity: Talk or presentation typesOral presentation

ISTH 2019 : The XXVII Congress of the International Society on Thrombosis and Haemostasis

Jonathan Douxfils (Member of Scientific Committee)
6 Jul 201910 Jul 2019

Activity: Participating in or organising an event typesParticipation in conference

ISTH 2019 : The XXVII Congress of the International Society on Thrombosis and Haemostasis

Jonathan Douxfils (Invited Speaker)
6 Jul 201910 Jul 2019

Activity: Participating in or organising an event typesParticipation in conference

Portola Pharmaceuticals

Jonathan Douxfils (Expert)
7 Jul 2019

Activity: Consultancy typesConsultancy

Clinical Debate: There is a need for DOAC testing in emergency situations and elective preoperative setting - YES

Jonathan Douxfils (Invited speaker)
14 Jun 2019

Activity: Talk or presentation typesOral presentation

Thesis

Evaluation of thrombotic and/or bleeding risks associated with anticoagulotherapy.

Author: Douxfils, J., 24 Oct 2015

Supervisor: Dogne, J. (Supervisor), Mullier, F. (Supervisor), Masereel, B. (President), Chatelain, B. (Jury), Chatelain, C. (External person) (Jury), Verhamme, P. (External person) (Jury), TEN CATE, H. (External person) (Jury) & Ageno, W. (External person) (Jury)

Student thesis: Doc typesDoctor of Biomedical and Pharmaceutical Sciences

Therapeutic monitoring of new oral anticoagulant: focus on dabigatran

Author: Douxfils, J., 2012

Supervisor: Dogne, J. (Supervisor)

Student thesis: Master typesMaster in Pharmacy

Press / Media

La thrombose en point de mire

Jonathan Douxfils

21/02/18

1 media contribution

Press/Media: Research

L'UNamur lance son labo pour combattre la thrombose

Jonathan Douxfils

6/12/17

1 media contribution

Press/Media: Research

Qualiblood combat la thrombose

Jonathan Douxfils

5/12/17

1 media contribution

Press/Media: Research

Vascular Occlusion Risk Reviewed For CML New-Generation TKIs

Jonathan Douxfils

17/02/16

1 item of media coverage

Press/Media: Expert Comment